New Procedure for co-ordinating GCP-Inspections
Recommendation

16-18 June 2026
Management, Supply and Quality Assurance of Clinical Trials
The GCP Inspectors Working Group of the European Medicines Agency (EMA) has finally published the Procedure for coordinating GCP inspections requested by the CHMP (EMA/INS/GCP/55482/2013).
This procedure describes the different steps of the Good Clinical Practice (GCP) inspection process and particularly the interfaces between Member States inspection services and the Committee for Medicinal Products for Human Use (CHMP)/European Medicines Agency (EMA).
It describes the overall process from preparation and adoption of the inspection request, designation of responsibilities within the inspection team up to the writing and circulation of inspection reports.
Related GMP News
03.06.2026In-use Storage Time of Reconstituted Medicines
28.05.2026New EMA Q&A on the Implementation of 3DP Technology
28.05.2026EMA publishes Presentations on Contractual Agreements in Clinical Trials
28.05.2026UK Substantial Modifications Pilot
07.05.2026What are the GMP Requirements for Investigational Medicinal Products (IMPs)?


